10 BÜCHER, DIE MIT «PROTEASE INHIBITOR» IM ZUSAMMENHANG STEHEN
Entdecke den Gebrauch von
protease inhibitor in der folgenden bibliographischen Auswahl. Bücher, die mit
protease inhibitor im Zusammenhang stehen und kurze Auszüge derselben, um seinen Gebrauch in der Literatur kontextbezogen darzustellen.
1
Plant
Protease Inhibitors: Significance in Nutrition, Plant ...
This book focuses on the isolation, structure, characterization, physiochemical and physiological properties, synthesis, functions and mechanisms of action of plant protease inhibitors.
2
Viral Proteases and Antiviral
Protease Inhibitor Therapy: ...
This volume represents a timely and valuable continuation of the PBAD series. Viral infections are still difficult to threat and some remained life-threatening diseases in spite of antiviral drug research over decades.
Uwe Lendeckel, N. M. Hooper, 2009
3
Biochemistry and Molecular Biology Compendium
While protease inhibitor cocktails have been in use for some time,1 there are few
rigorous studies examining their effect on proteolysis and very few concerned
with proteolytic degradation during the processing of material for analysis or
during ...
4
Studies in Natural Products Chemistry: Bioactive Natural ...
Plant protease inhibitor proteins can be either constitutive or inducible as a result
of wounding or pathogen invasion. Proteases are classified into the aspartic
proteases, cysteine proteases, metalloproteases and serine proteases on the
basis ...
5
Peptide and Protein Drug Analysis
A first case study of protease inhibitor design which illustrates the peptide
scaffold -based approach is that for HIV protease inhibitors. Albeit over the past
several years HIV protease inhibitor research has become a highly advanced
example ...
6
Protease Inhibitors: Advances in Research and Application: ...
Secretory Leukocyte Protease Inhibitor McGill University, Montreal: Beneficial
effects of secretory leukocyte protease inhibitor after spinal cord injury “Secretory
leukocyte protease inhibitor is a serine protease inhibitor produced by various
cell ...
7
AIDS-Related Cancers and Their Treatment
The recommended regimen to best achieve these results consists of two
nucleoside reverse transcriptase inhibitors with a potent bioavailable protease
inhibitor (Tables 1–3). For patients in whom the use of a protease inhibitors is not
feasible, ...
Ellen G. Feigal, Alexandra M. Levine, Robert J. Biggar, 2000
8
Advances in Viral Genome Research and Application: 2013 ...
... that a combination of anti-HIV compounds, which target reverse transcriptase (
RT), such as azidothymidine (AZT), lamivudine (3TC), dideoxyinosine (ddI),
dideoxycytidine (ddC) used in combination with an HIV-1 protease inhibitor have
a far ...
9
Oxford Textbook of Medicine: Infection
... HIV Protease inhibitor Atazanavir HIV Protease inhibitor Darunavir HIV
Protease inhibitor Indinavir HIV Protease inhibitor Fosamprenavir HIV Protease
inhibitor Lopinavir HIV Protease inhibitor Nelfinavir HIV Protease inhibitor
Ritonavir HIV ...
David Warrell, Timothy M. Cox, John Firth, 2012
10
HIV/AIDS: New Insights for the Healthcare Professional: 2013 ...
... that a combination of anti-HIV compounds, which target reverse transcriptase (
RT), such as azidothymidine (AZT), lamivudine (3TC), dideoxyinosine (ddI),
dideoxycytidine (ddC) used in combination with an HIV-1 protease inhibitor have
a far ...
10 NACHRICHTEN, IN DENEN DER BEGRIFF «PROTEASE INHIBITOR» VORKOMMT
Erfahre, worüber man in den einheimischen und internationalen Medien spricht und wie der Begriff
protease inhibitor im Kontext der folgenden Nachrichten gebraucht wird.
Hypoxia down-regulates expression of secretory leukocyte protease …
Secretory leukocyte protease inhibitor (SLPI) is a protein with anti-protease and antimicrobial properties that is constitutively secreted from the airway epithelium. «BMC Pediatrics, Mär 15»
Fat, Lean Mass Grows With Raltegravir and Protease Inhibitors
Patients with HIV who undergo treatment with the integrase inhibitor raltegravir (Isentress) or with protease inhibitors appeared to gain similar lean mass and ... «MedPage Today, Feb 15»
US Food and Drug Administration Approves Bristol-Myers Squibb's …
Evotaz is coformulated to be one pill, once-daily, combining the protease inhibitor atazanavir, which is marketed as Reyataz (atazanavir 200 mg/300 mg) ... «Business Wire, Jan 15»
Protease inhibitor monotherapy: darunavir/ritonavir less effective …
Monotherapy with a boosted protease inhibitor has been proposed as a form of maintenance therapy in people who have achieved viral load suppression, as a ... «aidsmap, Nov 14»
Second Wave Anti-HCV Protease Inhibitors
The NS3/4A Protease inhibitors Telaprevir and Boceprevir, have been a major breakthrough for patients and clinicians as they finally allowed patients with HCV ... «Medscape, Okt 14»
Enanta Pharmaceuticals Announces the Initiation of Phase 2b …
“The goal of our collaboration's next-generation protease inhibitor program is a pan-genotypic, ribavirin-free, once-daily dosing regimen for HCV patients,” stated ... «Business Wire, Sep 14»
Protease inhibitor therapy increases underlying genetic risk of …
Treatment with an antiretroviral regimen based on a protease inhibitor magnifies any underlying genetic susceptibility to diabetes for women living with HIV, ... «aidsmap, Jul 14»
Novel Role of the Serine Protease Inhibitor Elafin in Gluten-related …
Objectives: Elafin, an endogenous serine protease inhibitor, modulates colonic inflammation. We investigated the role of elafin in celiac disease (CD) using ... «Medscape, Jun 14»
Enanta Pharmaceuticals Announces US FDA Grants Priority Review …
ABT-450 is Enanta's lead protease inhibitor developed through Enanta's ... regulatory approval milestones and royalties on U.S. sales of that protease inhibitor. «MarketWatch, Jun 14»
People starting therapy on a boosted protease inhibitor don't need to …
Remaining on the same regimen is a “reasonable” strategy for people taking first-line antiretroviral therapy (ART) based on a ritonavir-boosted protease inhibitor ... «aidsmap, Jun 14»
